253 related articles for article (PubMed ID: 32172363)
1. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis.
Song HJ; Jiang X; Henry L; Nguyen MH; Park H
Eur J Clin Pharmacol; 2020 Jun; 76(6):851-866. PubMed ID: 32172363
[TBL] [Abstract][Full Text] [Related]
2. Use of proton pump inhibitors and the risk of hepatocellular carcinoma: A systematic review and meta-analysis.
Chang TE; Huang YS; Perng CL; Huang YH; Hou MC
J Chin Med Assoc; 2019 Oct; 82(10):756-761. PubMed ID: 31335628
[TBL] [Abstract][Full Text] [Related]
3. Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysis.
Wang J; Wu Y; Bi Q; Zheng X; Zhang J; Huang W
Hepatol Int; 2020 May; 14(3):385-398. PubMed ID: 31912308
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors associated with an increased risk of mortality in elderly: a systematic review and meta-analysis.
Song HJ; Seo HJ; Jiang X; Jeon N; Lee YJ; Ha IH
Eur J Clin Pharmacol; 2024 Mar; 80(3):367-382. PubMed ID: 38147074
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C.
Kao WY; Su CW; Chia-Hui Tan E; Lee PC; Chen PH; Tang JH; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
Hepatology; 2019 Mar; 69(3):1151-1164. PubMed ID: 30175498
[TBL] [Abstract][Full Text] [Related]
6. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis.
Tantai XX; Yang LB; Wei ZC; Xiao CL; Chen LR; Wang JH; Liu N
World J Gastroenterol; 2019 Jun; 25(21):2683-2698. PubMed ID: 31210719
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.
Cheungpasitporn W; Thongprayoon C; Kittanamongkolchai W; Srivali N; Edmonds PJ; Ungprasert P; O'Corragain OA; Korpaisarn S; Erickson SB
Ren Fail; 2015 Aug; 37(7):1237-41. PubMed ID: 26108134
[TBL] [Abstract][Full Text] [Related]
9. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
[TBL] [Abstract][Full Text] [Related]
10. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
[TBL] [Abstract][Full Text] [Related]
12. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
[TBL] [Abstract][Full Text] [Related]
13. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
Ayyagari S; Tan MC; Liu Y; El-Serag HB; Thrift AP
Dig Dis Sci; 2020 Sep; 65(9):2691-2699. PubMed ID: 31802383
[TBL] [Abstract][Full Text] [Related]
14. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of proton pump inhibitors and risk of digestive tract cancers.
Zeng R; Cheng Y; Luo D; Wang J; Yang J; Jiang L; Zhuo Z; Guo K; Wu H; Leung FW; Sha W; Chen H
Eur J Cancer; 2021 Oct; 156():190-201. PubMed ID: 34481369
[TBL] [Abstract][Full Text] [Related]
16. Association between proton pump inhibitors and the risk of hepatocellular carcinoma.
Shao YJ; Chan TS; Tsai K; Wu SY
Aliment Pharmacol Ther; 2018 Aug; 48(4):460-468. PubMed ID: 29897132
[TBL] [Abstract][Full Text] [Related]
17. Meta-Analysis of Efficacy and Safety of Proton Pump Inhibitors with Dual Antiplatelet Therapy for Coronary Artery Disease.
Khan SU; Lone AN; Asad ZUA; Rahman H; Khan MS; Saleem MA; Arshad A; Nawaz N; Sattur S; Kaluski E
Cardiovasc Revasc Med; 2019 Dec; 20(12):1125-1133. PubMed ID: 30773427
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.
Lo WK; Chan WW
Clin Gastroenterol Hepatol; 2013 May; 11(5):483-90. PubMed ID: 23270866
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies.
Srinutta T; Chewcharat A; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Jaber BL; Susantitaphong P
Medicine (Baltimore); 2019 Nov; 98(44):e17788. PubMed ID: 31689852
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
Shi D; Zhou Z; Dai Y; Pan X; Cao Q
Clin Drug Investig; 2019 Sep; 39(9):847-856. PubMed ID: 31183628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
